Q1 2024 13F Holders as of 31 Mar 2024
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
52,992,611
-
Total 13F shares
-
5,090,000
-
Share change
-
+4,308,232
-
Total reported value
-
$15,715,858
-
Price per share
-
$3.07
-
Number of holders
-
34
-
Value change
-
+$12,671,335
-
Number of buys
-
27
-
Number of sells
-
10
Institutional Holders of Immix Biopharma, Inc. - Common Stock (IMMX) as of Q1 2024
As of 31 Mar 2024,
Immix Biopharma, Inc. - Common Stock (IMMX) was held by
34 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
5,090,000 shares.
The largest 10 holders included
AIGH Capital Management LLC, Bleichroeder LP, Cable Car Capital LLC, VANGUARD GROUP INC, Lynwood Capital Management Inc., RENAISSANCE TECHNOLOGIES LLC, GEODE CAPITAL MANAGEMENT, LLC, Private Advisor Group, LLC, SUSQUEHANNA INTERNATIONAL GROUP, LLP, and CORSAIR CAPITAL MANAGEMENT, L.P..
This page lists
34
institutional shareholders reporting positions in this security
for the Q1 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.